Prot #2102-ONC-102: A Phase 1b/2 Study of FT-2102 in Patients with Advanced Solid Tumors and Gliomas with an IDH1 Mutation

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusActive
Effective start/end date4/17/194/17/22

Funding

  • Novella Clinical, LLC (Prot #2102-ONC-102)
  • FORMA Therapeutics, Inc. (Prot #2102-ONC-102)